Change of Immune Cell of ARDS Patients：an Observational Study

N/AUnknownNCT02958748

Southeast University, China60 enrolled

Overview

To evaluate change of different immune cellsduring ARDS and its impact on prognosis.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Intensive Care Medicine ARDS

Interventions

taking blood sampleOTHER

Eligibility

Sex: ALLMin age: 16 YearsMax age: 90 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: ①sign on the acknowledged ②Diagnosis with ARDS(The Berlin definition），onset within 48hours Exclusion Criteria: ①diagnosis of hematological or immunological disease ②treatment with chemotherapy agents or corticosteroids within 6 months prior to or during the hospitalization.

Outcomes

Primary Outcomes

mortality

Time frame: 28-day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.